David Toung
Stock Analyst at Argus Research
(4.53)
# 1,006
Out of 4,534 analysts
335
Total ratings
62.8%
Success rate
9%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Rated: Buy | $450 → $370 | $319.44 | +15.83% | 12 | Jul 9, 2026 | |
| IART Integra LifeSciences Holdings | Upgraded: Buy | $25 | $19.27 | +29.74% | 7 | Jun 17, 2026 | |
| LH Labcorp Holdings | Maintained: Buy | $310 | $283.14 | +9.49% | 3 | Jun 2, 2026 | |
| IQV IQVIA Holdings | Maintained: Buy | n/a | $204.06 | - | 5 | May 29, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | n/a | $86.01 | - | 2 | May 21, 2026 | |
| PFE Pfizer | Maintained: Buy | $35 | $24.94 | +40.36% | 12 | May 6, 2026 | |
| BSX Boston Scientific | Rated: Buy | $130 → $95 | $43.67 | +117.54% | 10 | Apr 24, 2026 | |
| DHR Danaher | Rated: Buy | $265 → $230 | $203.13 | +13.23% | 5 | Apr 23, 2026 | |
| UNH UnitedHealth Group | Upgraded: Buy | $400 | $425.14 | -5.91% | 14 | Apr 21, 2026 | |
| MDT Medtronic | Maintained: Buy | $115 | $83.05 | +38.47% | 18 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $290 → $180 | $157.08 | +14.59% | 16 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 → $400 | $305.89 | +30.77% | 19 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $110 → $95 | $62.80 | +51.27% | 3 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $81.14 | - | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $406.00 | - | 21 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 → $68 | $71.81 | -5.31% | 10 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $200 | $218.65 | -8.53% | 11 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $610 | $527.12 | +15.72% | 9 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 | $251.90 | -16.63% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $570 → $775 | $828.07 | -6.41% | 15 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $384.44 | n/a | 5 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 | $100.50 | n/a | 12 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.45 | n/a | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $165 → $175 | $210.52 | n/a | 2 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $955.71 | n/a | 1 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $371.44 | n/a | 4 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $450 → $520 | $346.45 | n/a | 8 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $150 | $90.41 | n/a | 15 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $665 → $770 | $1,171.28 | n/a | 9 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $265 → $300 | $366.78 | n/a | 5 | Nov 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 → $125 | $127.08 | n/a | 10 | Jun 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $75 | $133.98 | n/a | 11 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $60.98 | n/a | 6 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 → $140 | $254.94 | n/a | 14 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $152.28 | n/a | 2 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $228.24 | n/a | 10 | Aug 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $203.40 | n/a | 1 | Feb 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $19 | $4.90 | n/a | 3 | Oct 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $22.08 | n/a | 3 | Aug 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $21 | $44.25 | n/a | 1 | Apr 5, 2016 |
Stryker
Jul 9, 2026
Rated: Buy
Price Target: $450 → $370
Current: $319.44
Upside: +15.83%
Integra LifeSciences Holdings
Jun 17, 2026
Upgraded: Buy
Price Target: $25
Current: $19.27
Upside: +29.74%
Labcorp Holdings
Jun 2, 2026
Maintained: Buy
Price Target: $310
Current: $283.14
Upside: +9.49%
IQVIA Holdings
May 29, 2026
Maintained: Buy
Price Target: n/a
Current: $204.06
Upside: -
Edwards Lifesciences
May 21, 2026
Maintained: Buy
Price Target: n/a
Current: $86.01
Upside: -
Pfizer
May 6, 2026
Maintained: Buy
Price Target: $35
Current: $24.94
Upside: +40.36%
Boston Scientific
Apr 24, 2026
Rated: Buy
Price Target: $130 → $95
Current: $43.67
Upside: +117.54%
Danaher
Apr 23, 2026
Rated: Buy
Price Target: $265 → $230
Current: $203.13
Upside: +13.23%
UnitedHealth Group
Apr 21, 2026
Upgraded: Buy
Price Target: $400
Current: $425.14
Upside: -5.91%
Medtronic
Apr 6, 2026
Maintained: Buy
Price Target: $115
Current: $83.05
Upside: +38.47%
Mar 20, 2026
Rated: Buy
Price Target: $290 → $180
Current: $157.08
Upside: +14.59%
Mar 17, 2026
Reiterated: Buy
Price Target: $280 → $400
Current: $305.89
Upside: +30.77%
Mar 3, 2026
Rated: Buy
Price Target: $110 → $95
Current: $62.80
Upside: +51.27%
Dec 12, 2025
Maintained: Buy
Price Target: n/a
Current: $81.14
Upside: -
Dec 8, 2025
Maintained: Hold
Price Target: n/a
Current: $406.00
Upside: -
Nov 20, 2025
Rated: Buy
Price Target: $65 → $68
Current: $71.81
Upside: -5.31%
Nov 17, 2025
Upgraded: Buy
Price Target: $200
Current: $218.65
Upside: -8.53%
Oct 28, 2025
Maintained: Buy
Price Target: $610
Current: $527.12
Upside: +15.72%
Oct 14, 2025
Maintained: Buy
Price Target: $210
Current: $251.90
Upside: -16.63%
Aug 20, 2025
Rated: Buy
Price Target: $570 → $775
Current: $828.07
Upside: -6.41%
Jul 21, 2025
Downgraded: Hold
Price Target: n/a
Current: $384.44
Upside: n/a
Apr 21, 2025
Maintained: Buy
Price Target: $150
Current: $100.50
Upside: n/a
Mar 26, 2025
Maintained: Hold
Price Target: n/a
Current: $9.45
Upside: n/a
Oct 24, 2024
Maintained: Buy
Price Target: $165 → $175
Current: $210.52
Upside: n/a
Aug 15, 2024
Rated: Buy
Price Target: n/a
Current: $955.71
Upside: n/a
Aug 1, 2024
Maintained: Buy
Price Target: n/a
Current: $371.44
Upside: n/a
Jul 23, 2024
Maintained: Buy
Price Target: $450 → $520
Current: $346.45
Upside: n/a
May 20, 2024
Upgraded: Buy
Price Target: $150
Current: $90.41
Upside: n/a
Feb 7, 2024
Maintained: Buy
Price Target: $665 → $770
Current: $1,171.28
Upside: n/a
Nov 6, 2023
Maintained: Buy
Price Target: $265 → $300
Current: $366.78
Upside: n/a
Jun 6, 2023
Maintained: Buy
Price Target: $115 → $125
Current: $127.08
Upside: n/a
Jan 28, 2022
Upgraded: Buy
Price Target: $75
Current: $133.98
Upside: n/a
Nov 1, 2021
Downgraded: Hold
Price Target: n/a
Current: $60.98
Upside: n/a
Aug 5, 2021
Maintained: Buy
Price Target: $115 → $140
Current: $254.94
Upside: n/a
Mar 10, 2021
Downgraded: Hold
Price Target: n/a
Current: $152.28
Upside: n/a
Aug 27, 2019
Downgraded: Hold
Price Target: n/a
Current: $228.24
Upside: n/a
Feb 16, 2018
Downgraded: Hold
Price Target: n/a
Current: $203.40
Upside: n/a
Oct 21, 2016
Reiterated: Buy
Price Target: $17 → $19
Current: $4.90
Upside: n/a
Aug 15, 2016
Maintained: Hold
Price Target: n/a
Current: $22.08
Upside: n/a
Apr 5, 2016
Downgraded: Hold
Price Target: $21
Current: $44.25
Upside: n/a